Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG 897 - 401.

Slides:



Advertisements
Similar presentations
Evaluation of Movement Disorders
Advertisements

Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG
Parkinson’s Finding the cure Presentation
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
Diagnostic Method Diagnosis Diagnosis means `through knowledge` and entails acquisition of data about the patient and their complaints using the senses:
Knowledge and Attitudes Toward Genetic Testing in Parkinson’s Disease Dana Lundberg 2006.
Parkinson’s Disease Dr.Shamekh M. El-Shamy. Definition:
Parkinson’s disease Interventions Whitney Mundy Dr. Davis.
Brain Scan Imaging MRI, CAT, PET Imaging Interpreting Functions of the Brain through Imaging – Activity Case Study – Professional Sports and Head Trauma.
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
Parkinson’s Test Device Development Erin Sikkel and Tiffany Feltman.
Nerve Cell Regeneration Heather Wilson and Alicia DiCola.
Is it a neurodegenerative brain disorder that progresses slowly in most people.
Chapter 17 Nursing Diagnosis
Alzheimer’s patients Caregivers Survey in Greece Dr Paraskevi Sakka Neuropsychiatrist Chairwoman, Athens Association of Alzheimer’s Disease and Related.
Parkinson’s Disease Busra Berika Yucel
Nervous System Human Body Systems Project Caroline Crinion.
The Nature of Disease.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Section 24.1 The Healthcare System Slide 1 of 33 Objectives Identify the healthcare providers that work together to care for patients. Describe different.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Abnormal psychology Concepts and diagnosis © Hodder & Stoughton 2013.
Parkinson’s Disease superKAT :).
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
Sudipta Sen 2 nd June 2015 INTEGRATED/COLLABORATIVE CARE IN ADHD MANAGEMENT.
Parkinson’s Disease by Jessica Teen Health 8 Definition *Parkinson’s Disease is a disorder of the brain characterized by shaking and having difficulty.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
PARKINSON’S DISEASE BY: NICOLE MABARDI & SHAINA JOSEPH.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
Neurological Disorders
By Katelyn Chaimson and Sean Guyot
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Principles of Assessment and Outcome Measurement for Physical Therapists ksu. edu. sa Dr. taher _ yahoo. com Mohammed TA, Omar,
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Pathogenesis and pathology of parkinsonism
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
Global Parkinson’s Disease Market Report: 2016 Edition Phone No.: +1 (214) id:
Parkinson’s Disease in Africa Jacques Doumbé MD Department of Neurology Douala Laquintinie Hospital Cameroon.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Research Methodology Proposal Prepared by: Norhasmizawati Ibrahim (813750)
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
History of Treatment Module 70. History of Treatment What to do with the severely disturbed? –middle Ages to 17th century madness = in league with devil.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Patient #4 - Parkinson’s Disease
Sleep and Parkinson’s Disease
Parkinson’s Disease Jose S. Santiago M.D..
MOVEMENT DISORDERS.
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Parkinson’s Disease Celsey and Chylee.
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
BRIC Neonatal Monitors Market Outlook
Parkinson's disease Parkinson's disease (PD) is the second-most common
Quantitative Detection of Parkinson's Disease Symptoms
Unit 14 – Physiological disorders
Canada Cardiovascular Prosthetic Devices Market Outlook to 2020
Introduction To Medical Technology
Decision Trees Showcase
Detecting and Diagnosing Alzheimer’s Disease
Presentation transcript:

Analyzing the Potential of a Diagnostic Tool for PD Ben Oren, Ezra Brettler, Uri Ron, and Ying Wang MKTG

Client: Jafar Sabbah, CEO, Dental Devices Ltd. Technology in question: a novel computerized system for automatic quantification and measurement of time-space patterns of facial features during facial expression System is intended as a monitoring and decision support tool for the detection, and progression evaluation of medical disorders that affect the performance of facial muscles Currently system is exploited in a study on Parkinson’s Disease (PD) Project Background

Determining whether there is a real market need for an objective diagnostic computerized system for degenerative diseases such as PD This is the central question in the decision of whether to provide the inventors with seed money and bring the technology into the NGT Project Objectives

Parkinson’s Disease is the most common neurodegenerative disorder after Alzheimer's disease 4-6 million people worldwide have been diagnosed with PD ~1 million people in U.S. It is estimated that an additional 3 million people have undiagnosed PD in the U.S. The prevalence (of those diagnosed with PD) is estimated at being 0.3% in the whole population in industrialized countries Rising to 1% in those over 60 years of age 4% of the population over 80 Mean age of onset is ~60 years, but 5-10% of cases are considered young onset (cases with PD beginning between the ages of 20 and 50) U.S. incidence is ~17 per 100,000 of population per year PD Prevalence and Incidence

Physicians arrive at a diagnosis of PD using both subjective judgment and interpretation Assessing a patient’s history Performing a physical examination on the patient Requires intimate familiarity with the signs and symptoms found Accuracy of diagnosis increases with progression of the disease Current methods and scales: UPDRS UK Brain bank Criteria Gelb Criteria CAPIT Criteria Hoehn and Yahr Scale Current Diagnosis Protocol

Two of the four main symptoms must be present over a specific time period for a neurologist to consider a PD diagnosis Tremor or shaking Bradykinesia - Slowness of movement Rigidity (stiffness) of the arms, legs or trunk Postural instability - Balance problems and possible falls Brain changes that create neurodegenerative diseases are microscopic (on a chemical level) and are Not Revealed by scanning technology Current Scanning Methods: Electroencephalograms (EEGs) MRI and CAT Scans Positron Emission Tomography (PET Scan) Current Diagnosis Protocol - Cont’d

We interviewed 5 professionals that specialize in the area of PD Sample included researchers, and both primary care and specialist physicians Goals of primary research: Determine which of available methods is most preferred for both diagnosis and monitoring progression of PD Gather more information about the awareness of facial twitches and irregularities as a significant symptom of PD Determine whether there is potential to fill an unmet need through the measurement of facial expressions Goals of primary research and sample questions

According to our research based on industry standard survey conducted by NOP World Response to pharmacotherapy and MRIs are the most popular diagnostic and confirmatory procedures used for patients (showed in bottom right panel) Neurologists’ PD patients experience more tremors (52%) than any other symptom. Wearing-off fluctuations and early morning akinesia symptoms are both seen in about a quarter of PD patients (showed in bottom left Panel) According to NEUROs, PCPs are their largest referral source of PD patients. It is very helpful if there is a tool to help PCP diagnose PD disease. Results of primary research 1 of 3 % of PD Patients Who Undergo Each Procedure for Diagnosis % of Patients

One-on-one telephone interviews were conducted focused on Neuros and PCP. Three Neuros and one PCP were interviewed. Head of Parkinson Disease research, education and clinical center in US Assistant Professor, General Internal Medicine, Johns Hopkins University Xxx Xxxx The results are primarily focused on the following areas Symptoms used to diagnose PD Equipment used to diagnose PD What is the biggest unmet need Results of primary research 2 of 3

Symptoms used to diagnose PD asymmetric resting tremor responsiveness to dopaminergic replacement therapy Cogwheel rigidity rigidity Nearly no patients with PD have facial asymmetry and twitching, but most have facial masking and it can occur early Equipment used to diagnose PD Current equipments used to diagnose PD are viewed somewhat reliable, but rely on physicians’ experience for diagnosis. Some of the equipments require a lot of prep work and intensive training What is the biggest unmet need Physicians consistently categorize the level of unmet need as “high demand” They view the most challenge comes from diagnosing he patient early in the disease progression and differentiating PD for other atypical and secondary forms of Parkinsonism Interviewees’ opinion on the proposed method not asymmetry or facial twitching, which normally don’t occur in PD, but masked faces might be useful for diagnosis but probably not as a biomarker of disease progression because it is treatment responsive and the degree of change over time is subtle Results of primary research 3 of 3

Findings and Recommendations 1 of 2

Findings and Recommendations 2 of 2

Potential Next Steps